Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business Sort descending
  • Functional Area
  • Date Posted
Job Title Site Location Division Business Sort descending Functional Area Date Posted
Procure to Pay Business Partner Management INSURGENTES Mexico Finance CTS Audit & Finance Oct 16, 2024
Order to Cash RLT Sr. Specialist INSURGENTES Mexico Finance CTS Audit & Finance Oct 16, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Associate Director of Forensics Hyderabad (Office) India Operations CTS Technology Transformation Oct 10, 2024
Assoc. Dir. Solution Delivery - SAP FICO Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 10, 2024
Director, Marketing & Digital Data Solution Hyderabad (Office) India Operations CTS Marketing Oct 10, 2024
Director Data Stratagy Hyderabad (Office) India Operations CTS Marketing Oct 10, 2024
Sr. Spec. DDIT IES Projects Hyderabad (Office) India Operations CTS Technology Transformation Oct 10, 2024
Sr. Spec. DDIT IES Projects Hyderabad (Office) India Operations CTS Technology Transformation Oct 10, 2024
Legal Trainee - Legal Procurement, Data/Digital & IT Basel (City) Switzerland Legal CTS Others Oct 10, 2024
Solution Delivery- SAP SME (BTP & CPI) Prague Czech Republic Operations CTS Technology Transformation Oct 10, 2024
Assistant Manager - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Oct 17, 2024
Associate Director - Technology Modernization(Application Portfolio Management, Project/Program Management) Hyderabad (Office) India Operations CTS Technology Transformation Oct 18, 2024
IT Senior Project Manager Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 18, 2024
Director of Global & Swiss Media & Editorial Basel (City) Switzerland Corporate CTS Communications & Public Affairs Oct 18, 2024
Sr. Spec. DDIT ISC Gov GxP Assessments Hyderabad (Office) India Operations CTS Technology Transformation Oct 18, 2024
Sr. Spec. DDIT IES Supplier Management Hyderabad (Office) India Operations CTS Information Technology Oct 18, 2024
LDC Adopt Process Lead - Taxes INSURGENTES Mexico Operations CTS Audit & Finance Aug 19, 2024
TCM Senior Cash Management Specialist INSURGENTES Mexico Operations CTS Audit & Finance Aug 30, 2024
Record to Report Specialist INSURGENTES Mexico Finance CTS Audit & Finance Sep 05, 2024
Record to Report Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Record to Report Sr Specialist Intercompany INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Record to Report Sr Specialist US INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Fixed Assets Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Fixed Assets Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Buyer LACan (Temporary) INSURGENTES Mexico Operations CTS Procurement Sep 15, 2024
Order Management Specialist - Temporary INSURGENTES Mexico Finance CTS Audit & Finance Sep 25, 2024
Procure to Pay Business Partner GDD and M&A SPOC INSURGENTES Mexico Operations CTS Audit & Finance Sep 27, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Procure to Pay Senior Specialist MR11 INSURGENTES Mexico Finance CTS Audit & Finance Jul 23, 2024
Order to Cash Radioligand Therapy Sr. Specialist INSURGENTES Mexico Finance CTS Audit & Finance Aug 06, 2024
IT Program/ Project Manager Clinical Analytics Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 16, 2024
Pricing Manager Dublin (Country President Office (CPO)) Ireland International CTS Market Access Oct 16, 2024
Project Manager, M&A IT Prague Czech Republic Operations CTS Technology Transformation Oct 16, 2024
Associate Director, Enterprise Architect Network Security Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 16, 2024
Human Resources Services Expert with German Prague Czech Republic People & Organization CTS Human Resources Oct 16, 2024
Comms & Engagement Manager Amsterdam Netherlands Corporate Affairs CTS Communications & Public Affairs Oct 16, 2024
Executive Director, Therapy Area Communications and Patient Advocacy Basel (City) Switzerland Corporate Affairs CTS Communications & Public Affairs Oct 16, 2024
H2R Services Expert Moscow (City) Russian Fed. People & Organization CTS Human Resources Oct 16, 2024
Manager - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Oct 16, 2024
Sr. Spec. DDIT IES NW Engg Hyderabad (Office) India Operations CTS Technology Transformation Oct 16, 2024
Senior Analyst Commercial Analytics Hyderabad (Office) India Operations CTS Marketing Oct 16, 2024
Snr. Specialist MDM (Master Data Management - implementation using Reltio) Hyderabad (Office) India Operations CTS Technology Transformation Aug 28, 2024
Snr Specialist(Power BI & Embedded Analytics - Web applications) Hyderabad (Office) India Operations CTS Technology Transformation Aug 28, 2024
Assoc. Dir Content Engineering(Azure -AWS-Application management Documentum) Hyderabad (Office) India Operations CTS Technology Transformation Sep 03, 2024
Financial Accounting Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Sep 13, 2024
Associate Director -Project Manager LDC Operations( SAP S4Hana SCM Applications) Hyderabad (Office) India Operations CTS Technology Transformation Sep 16, 2024
Strategic Design Commercial Contracts Manager Barcelona Gran Vía Spain Operations CTS Marketing Sep 24, 2024
Legal Trainee / Rechtsreferendar (m/f/d) in der Rechtsanwaltsstation oder im Pflichtwahlpraktikum Munich (Novartis Business Services GmbH) Germany Legal CTS Others Oct 04, 2024
Sr. Spec. DDIT IES Workforce Mgmt. Hyderabad (Office) India Operations CTS Technology Transformation Oct 03, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia